Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Enright Patrick G
Relationship:   10% Owner
City:   Burlingame
State:   CA
   
Insider Summary:
  
   
Companies Owned :   16    
Direct Shares   3,308,185    

Indirect Shares

  27,432,603      
Direct Value   $10,512,905    

Indirect Value

  $115,077,943      
Total Shares   30,740,788      
Total Value   $125,590,848      


Molecular Templates, Inc.
 $298 Sequenom Inc
 $0 Corcept Therapeutics Inc
 $8,214,718 Jazz Pharmaceuticals Inc
 $2,288,769 Aptinyx Inc.
 $9,120 Eargo, Inc.
 $0 Molecular Templates, Inc.
 $298 Sequenom Inc
 $0 Corcept Therapeutics Inc
 $8,214,718 Jazz Pharmaceuticals Inc
 $2,288,769 Aptinyx Inc.
 $9,120 Eargo, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    6   
    1    

     Stock price went up :

    5   
    1    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   5.0   
   1.0   
     Percentage Gain/Loss :
   95.0%
 101.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Molecular Templates, Inc. MTEM Director 2006-04-20 496 2007-03-01 0    Premium*  
            Sequenom Inc SQNM Director 2006-12-07 771 2006-12-07 3,333,333    Premium*  
            Corcept Therapeutics Inc CORT Director 2017-03-16 272,281 2017-03-16 114,675    Premium*  
            Jazz Pharmaceuticals Inc JAZZ Director 2023-08-14 20,946 2022-08-08 2,000    Premium*  
            Esperion Therapeutics, Inc. ESPR Director 2013-07-01 0 2015-03-19 18,361    Premium*  
            Collegium Pharmaceutical, Inc COLL 10% Owner 2015-05-12 0 2015-05-12 65,270    Premium*  
            Aimmune Therapeutics, Inc. AIMT Director 2020-10-13 0 2020-10-10 0    Premium*  
            Aptinyx Inc. APTX Director 2020-01-10 95,000 2020-01-10 3,356,746    Premium*  
            Tricida, Inc. TCDA 2018-07-02 0 2018-07-02 3,019,734    Premium*  
            Venus Concept Inc VERO 10% Owner 0 2019-11-07 3,666,119    Premium*  
            89bio, Inc. ETNB 10% Owner 2019-11-11 0 2020-11-16 891    Premium*  
            Sierra Oncology Inc SRRA 10% Owner 2020-01-29 0 2022-01-25 1,964,771    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 0 2022-04-19 4,174,379    Premium*  
            Eargo, Inc. EAR 10% Owner 2021-04-14 2,918,691 2021-04-14 5,012    Premium*  
            Vera Therapeutics, Inc. VERA Director, 10% Owner 2021-05-18 0 2023-02-06 5,144,212    Premium*  
            Lexeo Therapeutics, Inc. LXEO 10% Owner 2023-11-07 0 2023-11-07 2,567,100    Premium*  
* Premium Members only  

Records found :    169         Free Registration Required For Full Results.    Limit: 25

Download
  Page 3 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
CORT Corcept Therapeutics Inc Director   –       •       •   2016-11-28 4 D $0.00 $0 I/I (3,000,000) 121,153 0 -
CORT Corcept Therapeutics Inc Director   –       •       •   2016-12-12 4 A $0.00 $0 D/D 204,210 204,210 0 -
CORT Corcept Therapeutics Inc Director   –       •      –    2017-02-23 4 S $8.65 $12,975,000 I/I (1,500,000) 185,807 0 -
CORT Corcept Therapeutics Inc Director   –       •      –    2017-02-27 4 S $9.05 $9,050,000 I/I (1,000,000) 166,157 0 -
CORT Corcept Therapeutics Inc Director   –       •      –    2017-03-13 4 S $11.13 $233,491 I/I (20,980) 151,008 0 -
CORT Corcept Therapeutics Inc Director   –       •      –    2017-03-14 4 S $10.01 $3,002,670 I/I (300,000) 145,113 0 -
CORT Corcept Therapeutics Inc Director   –       •      –    2017-03-15 4 S $10.24 $2,856,766 I/I (279,020) 139,630 0 -
CORT Corcept Therapeutics Inc Director   –       •      –    2017-03-16 4 S $9.94 $2,683,237 I/I (269,955) 114,675 0 -
EAR Eargo, Inc. 10% Owner   –       –       •   2021-04-14 4 AS $0.00 $0 D/D (1,000,000) 2,918,691 0 -
EAR Eargo, Inc. 10% Owner   –       –       •   2021-04-14 4 A $0.00 $0 I/I 5,012 5,012 0 -
ESPR Esperion Therapeutics, In... Director   –       •       •   2013-07-01 4 B $14.00 $3,033,464 I/I 216,676 38,011 2.25 -
ESPR Esperion Therapeutics, In... Director   –       •       •   2013-07-01 4 A $0.00 $0 I/I 1,717,720 33,753 0 -
ESPR Esperion Therapeutics, In... Director   –       •       •   2014-10-07 4 S $30.04 $358,289 I/I (11,927) 37,776 0 -
ESPR Esperion Therapeutics, In... Director   –       •       •   2014-10-09 4 S $30.00 $28,290 I/I (943) 37,757 0 -
ESPR Esperion Therapeutics, In... Director   –       •       •   2014-11-17 4 S $32.01 $15,804,823 I/I (482,026) 28,286 0 -
ESPR Esperion Therapeutics, In... Director   –       •       •   2014-11-18 4 S $31.56 $161,346 I/I (5,104) 28,186 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2015-03-19 4 S $110.01 $55,831,597 I/I (500,000) 18,361 0 -
ETNB 89bio, Inc. 10% Owner   –       –       •   2019-11-11 4 B $16.00 $9,200,000 I/I 575,000 575,000 1.5 -
ETNB 89bio, Inc. 10% Owner   –       –       •   2019-11-13 4 A $0.00 $0 I/I 1,916,787 2,491,787 0 -
ETNB 89bio, Inc. 10% Owner   –       –       •   2020-07-10 4 B $27.50 $2,999,975 I/I 109,090 2,600,877 1.5 %
ETNB 89bio, Inc. 10% Owner   –       –       •   2020-11-16 4 A $0.00 $0 I/I 5,944 891 0 -
ETNB 89bio, Inc. 10% Owner   –       –       •   2020-11-16 4 D $0.00 $0 I/I (850,000) 1,750,877 0 -
INZY Inozyme Pharma, Inc. 10% Owner   –       –       •   2020-07-28 4 B $16.00 $10,000,000 I/I 625,000 2,819,379 1.5 -
INZY Inozyme Pharma, Inc. 10% Owner   –       –       •   2020-07-28 4 A $0.00 $0 I/I 2,194,379 2,194,379 0 -
INZY Inozyme Pharma, Inc. 10% Owner   –       –       •   2022-04-19 4 B $3.69 $4,999,950 I/I 1,355,000 4,174,379 1.5 -

  169  Records found
  1   2   3  4   5   6   7      
  Page 3 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed